TrACEing angiotensin II type 1 to right ventricular hypertrophy: are the "sartans" a viable course to treating pulmonary arterial hypertension?
- PMID: 23071186
- PMCID: PMC4522859
- DOI: 10.1164/rccm.201208-1480ED
TrACEing angiotensin II type 1 to right ventricular hypertrophy: are the "sartans" a viable course to treating pulmonary arterial hypertension?
Comment on
-
Dysregulated renin-angiotensin-aldosterone system contributes to pulmonary arterial hypertension.Am J Respir Crit Care Med. 2012 Oct 15;186(8):780-9. doi: 10.1164/rccm.201203-0411OC. Epub 2012 Aug 2. Am J Respir Crit Care Med. 2012. PMID: 22859525 Free PMC article.
References
-
- Abraham WT, Raynolds MV, Badesch DB, Wynne KM, Groves BM, Roden RL, Robertson AD, Lowes BD, Zisman LS, Voelkel NF, et al. Angiotensin-converting enzyme DD genotype in patients with primary pulmonary hypertension: increased frequency and association with preserved haemodynamics. J Renin Angiotensin Aldosterone Syst 2003;4:27–30. - PubMed
-
- Leier CV, Bambach D, Nelson S, Hermiller JB, Huss P, Magorien RD, Unverferth DV. Captopril in primary pulmonary hypertension. Circulation 1983;67:155–161. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
